Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

Podobne knjige/članki

• Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
  od: Harro, Clayton, et al.
  Izdano: (2009)
• Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
  od: Quirk, Erin K., et al.
  Izdano: (2014)
• Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
  od: Nicholson, Ouzama, et al.
  Izdano: (2011)
• Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
  od: Harro, Clayton D., et al.
  Izdano: (2009)
• Merck to pay $5bn in rofecoxib claims
  od: Charatan, Fred
  Izdano: (2007)